Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia)-Reference-Cited by-同舟云学术

Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia)

Published:2023-11 Issue:11 Volume:18 Page:1538-1549
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sakai Tetsuya^ORCID,Matsumoto Shingo,Ueda Yasuto,Shibata Yuji,Ikeda Takaya,Nakamura Atsushi,Kodani Masahiro,Ohashi Kadoaki,Furuya Naoki,Izumi Hiroki,Nosaki Kaname,Umemura Shigeki,Zenke Yoshitaka,Udagawa Hibiki,Sugiyama Eri,Yoh Kiyotaka,Goto Koichi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond;Holderfield;Nat Rev Cancer,2014

2. Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations;Marchetti;J Clin Oncol,2011

3. Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations;Paik;J Clin Oncol,2011

4. BRAF mutations in non-small cell lung cancer;Luk;Transl Lung Cancer Res,2015

5. Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer;Cardarella;Clin Cancer Res,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib‐induced BRAF mutation in a single metastatic lesion among multiple pulmonary lesions in a case of lung cancer with EGFR exon 19 deletion;Respirology Case Reports;2024-08

2. BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape;npj Precision Oncology;2024-04-16

3. Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report;OncoTargets and Therapy;2024-01

4. Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study;BMC Pulmonary Medicine;2023-12-01

5. Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation;Current Oncology;2023-11-19